Large-scale testing (Phase 3)Study completedNCT01696500
What this trial is testing
Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Nihon Pharmaceutical Co., Ltd 10